Medication and therapeutic paradigms are continually advancing the treatment of psychiatric disease. Yet a large population of patients remains refractory to noninvasive treatments. Surgical therapies for treatment-resistant depression, obsessive-compulsive disorder, post-traumatic stress disorder, and others have an extended track record of efficacy, and are evolving along with our technological capabilities, such as minimally invasive neurostimulation (e.g., deep brain stimulation). These technical advances are paralleled by advances in machine learning applied to neuroimaging, electrophysiology, and behavioral biomarkers of disease. This session will introduce the attendee to the current state of the art in surgical therapies for psychiatric disease, highlighting deep brain stimulation, vagus nerve stimulation, and lesioning procedures.
Upon completion of this educational activity, participants should be able to:
- Discuss the current landscape of clinical trials for DBS and VNS.
- Describe different targets for neurostimulation for depression and OCD.
- Identify currently available surgical therapies for psychiatric disorders.
- Compare and contrast lesioning with other forms of neuromodulation.
Sameer A. Sheth, MD PhD
Laser Ablation for Obsessive-Compulsive Disorder (OCD)
Nicole McLaughlin, PhD
Deep Brain Stimulation (DBS) for Depression
Darin D. Dougherty, MD
Adaptive Deep Brain Stimulation (DBS) for Obsessive-Compulsive Disorder (OCD)
Wayne Goodman, MD
Individualizing Deep Brain Stimulation (DBS) Therapy Using Intracranial EEG
Kelly R. Bijanki, PhD
Faculty and Presentations subject to change.
- Research in Neuromodulation: Trials and Tribulations
- Outcomes and Access to Neuromodulation for Women and Underrepresented Minorities: A Call to Action
- Engineering Principles of DBS and SCS in Clinical Practice: Emerging Concepts
- Open- vs. Closed-Loop Neurostimulation and Enabling Biomarkers
- American Academy of Pain Medicine (AAPM) Session: Integrating Neuromodulation Into Multimodal Pain Care